Kokate Rutika A

Department of Hematology/Oncology Fox Chase Cancer Center

关注

立即认领

关注

立即认领

基本信息

浏览量：41

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Multidisciplinary Educational Program to Standardize Education and Management of Immune-related Adverse Events

Matthew Zibelman, Victoria Wong, Jennifer Reilly, Carolyn Zawislak, Darrin Richman, Cynthia Keleher, Brianna Herron, Christine Rafferty, Tracy Tisone, Barbara Rogers,Rutika Kokate

American Journal of Clinical Oncology (2024)

引用0浏览0WOS引用

Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response after Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial

Elizabeth R. Plimack,Catherine Tangen,Melissa Plets,Rutika Kokate,Joanne Xiu,Chadi Nabhan,Eric A. Ross, Erin Grundy,Woonyoung Choi,Colin P. N. Dinney,I. -Ling C. Lee,Megan Fong,M. Scott Lucia,Siamak Daneshmand,Dan Theodorescu,Amir Goldkorn,Seth P. Lerner,Thomas W. Flaig,David J. McConkey

EUROPEAN UROLOGY（2024）

引用0浏览0WOS引用

Multi-omic Characterization of Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma

Eddy Saad,Chris Labaki,Benjamin Miron,Jihye Park,Ziad Bakouny,Amin Nassar,Renee Maria Saliby,Karl Semaan,Marc Eid,Kevin Meli,Yasmin Nabil Laimon,Daniel M. Geynisman,Rutika Kokate,David A. Braun,Sabina Signoretti,Bradley Alexander Mcgregor,Elizabeth R. Plimack,Toni K. Choueiri,Eliezer Mendel Van Allen,Matthew R. Zibelman

Journal of Clinical Oncologyno. 4_suppl (2024): 459-459

引用1浏览0引用

Figure S8 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

H. Josh Jang,Galen Hostetter,Alexander W. Macfarlane,Zachary Madaj,Eric A. Ross,Toshinori Hinoue,Justin R. Kulchycki,Ryan S. Burgos,Mahvish Tafseer,R. Katherine Alpaugh,Candice L. Schwebel,Rutika Kokate,Daniel M. Geynisman,Matthew R. Zibelman,Pooja Ghatalia,Peter W. Nichols,Woonbok Chung,Jozef Madzo,Noah M. Hahn,David I. Quinn,Jean-Pierre J. Issa,Michael J. Topper,Stephen B. Baylin,Hui Shen,Kerry S. Campbell,Peter A. Jones,Elizabeth R. Plimack

openalex（2023）

引用0浏览0引用

A Phase 1 Study of Nivolumab in Combination with Interferon-Gamma for Patients with Advanced Solid Tumors

Matthew Zibelman,Alexander W. MacFarlane IV, Kimberly Costello,Thomas McGowan,John O’Neill,Rutika Kokate,Hossein Borghaei,Crystal S. Denlinger,Efrat Dotan,Daniel M. Geynisman,Angela Jain,Lainie Martin,Elias Obeid,Karthik Devarajan,Karen Ruth,R. Katherine Alpaugh,Essel Al-Saleem Dulaimi,Edna Cukierman,Margret Einarson,Kerry S. Campbell,Elizabeth R. Plimack

Nature Communicationsno. 1 (2023)

引用7浏览0WOSNATURE引用

Figure S2 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

openalex（2023）

引用0浏览0引用

Figure S3 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

openalex（2023）

引用0浏览0引用

Figure S10 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

openalex（2023）

引用0浏览0引用

Figure S12 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

openalex（2023）

引用0浏览0引用

Supplementary Tables 1 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

openalex（2023）

引用0浏览0引用

加载更多

作者统计

#Papers: 35

#Citation: 337

H-Index: 10

G-Index: 18

Sociability: 5

Diversity: 2

Activity: 9

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn